Part of the work at Abliva consists of making the company’s activities visible in different public contexts, partly to increase understanding of the enormous medical needs of people with primary mitochondrial disease, but also to increase interest in the company among potential investors or partners.
Mitochondria-Targeted Drug Development 22 – 24 Feb 2022.
BioStock Life Science Summit 20 Oct 2021.
Aktiespararna: Kvinnokvällen (Women’s night) in Malmö 19 Oct 2021.
Aktiespararna: Kvinnokvällen (Women’s night) in Gothenburg 31 Aug 2021.
UMDF Mitochondrial Medicine symposium June 2021
Redeye Investor Forum Online 20 May 2021.
Redeye Orphan Drugs Seminar 28 April 2021.
Aktiedagen digitalt Stockholm 16 March 2021.
BioStock Live 9 March 2021.
Swiss Nordic Bio 2021 10 – 11 Feb 2021.
Mitochondrial Medicine 2020 30 Nov – 2 Dec.
Redeye Life Science Day 26 Nov 2020.
BioStock Life Science Summit 17 Nov 2020.
Aktiespararna: Kvinnokvällen (Women’s night) in Gothenburg. 12 October 2020.
10th Italian Meeting on Mitochondrial Diseases, 9-10 October 2020.
Abliva’s Mitochondria Day 16 September 2020.
UMDF’s Power Surge 26 June 2020
Abliva Capital Markets Day 23 June 2020
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".
Read our cookie policy